CYTARABINE (Hospira, Inc.)
Welcome to the PulseAid listing for the CYTARABINE drug offered from Hospira, Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Hospira, Inc. |
| NON-PROPRIETARY NAME: | CYTARABINE |
| SUBSTANCE NAME: | CYTARABINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 1990-08-31 |
| END MARKETING DATE: | 0000-00-00 |
CYTARABINE HUMAN PRESCRIPTION DRUG Details:
| Item Description | CYTARABINE from Hospira, Inc. |
| LABELER NAME: | Hospira, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/mL) |
| START MARKETING DATE: | 1990-08-31 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 61703-303_ec59aad2-fa83-46ec-acbf-e85ba890c3f5 |
| PRODUCT NDC: | 61703-303 |
| APPLICATION NUMBER: | ANDA072168 |
Other CYTARABINE Pharmaceutical Manufacturers / Labelers:
